Mettler Toledo International (NYSE:MTD – Earned Rating) It was downgraded from a ‘strong buy’ rating to a ‘buy’ rating by StockNews.com equity analysts in a research report issued Thursday.
Several other research analysts have also recently joined the company. Goldman Sachs Group upgraded Mettler’s Toledo International rating from ‘sell’ to ‘neutral’ in a research report on Tuesday, November 8, raising the company’s price target from $1,120.00 to his $1,355.00 raised to dollars. Wells Fargo & Company, in a research report on Tuesday, January 10, raised Mettler-Toledo International’s price target from $1,410.00 to $1,650.00, giving the company an “overweight” rating. Robert W. Baird lowered his price target for Mettler-Toledo International from $1,406.00 to $1,284.00 in a research report on Friday, November 4. Finally, JPMorgan Chase & Co. upgraded Mettler-Toledo International from an ‘underweight’ rating to a ‘neutral’ rating in a research report on Monday, December 19, setting the company’s price target at $1,100.00. Increased to $1,350.00. Four analysts rated the stock with a holding rating and three analysts gave the company’s stock a buy rating. According to MarketBeat data, Mettler-Toledo International currently has an average rating of “pending” and an average price target of $1,396.00.
Mettler Toledo International Trading down 0.2%
NYSE:MTD shares opened Thursday at $1,531.57. His 52-week low on the Mettler-Toledo International is $1,065.55 and his 52-week high is $1,583.40. The stock has a market cap of $34.14 billion, a price/earnings ratio of 41.91, a PEG ratio of 3.01, and a beta of 1.19. The company has a quick ratio of 0.74, a current ratio of 1.13 and a debt to equity ratio of 250.82. The 50-day moving average price for this business is $1,470.95 and the 200-day moving average price is $1,323.87.
Mettler-Toledo International (NYSE:MTD – Get Rating) last announced its quarterly earnings data on Thursday, November 3rd. The medical device supplier posted his earnings per share (EPS) of $10.18 for the quarter, $0.35 above consensus expectations of $9.83. Mettler-Toledo International had a return on equity of 1,929.28% and a net profit margin of 21.48%. The company posted revenue of $985.8 million for the quarter, compared with analyst estimates of $973.68 million. During the same period last year, the business posted earnings of $8.72 per share for him. The company’s revenue for the quarter increased by 3.6% compared to the same period last year. Equity analysts expect Mettler Toledo International to post 39.02 EPS this year.
Insider activity
In another news, Director Olivier A. Filliol sold 10,252 shares in the company in a transaction that took place on Tuesday, November 29th. The shares were sold at an average price of $1,420.65, giving him a total of $14,564,503.80. Following the closing of the sale, the directors now own 71 shares in the company directly, valued at $100,866.15. The transaction was disclosed in documents filed with the Securities and Exchange Commission and can be accessed at this link. In another news, Director Olivier A. Filliol sold his 6,448 Mettler shares in Toledo International in a transaction that took place on Thursday, December 1st. The shares were sold at an average price of $1,491.20, giving him a total of $9,615,257.60. After the sale, the directors now directly own 71 shares of the company stock valued at $105,875.20. The sale was disclosed in filings with the Securities and Exchange Commission, which can be accessed via this hyperlink. Olivier A. Filiol, director of Mettler, also sold 10,252 shares of Toledo International in a transaction that took place on Tuesday, November 29. The shares were sold at an average price of $1,420.65, giving him a total of $14,564,503.80. Following the closing of the sale, the directors now own 71 shares in the company directly, valued at $100,866.15. Please see here for the disclosure of this sale. Insiders say that in the past three months he has sold 37,073 shares of company stock worth $52,372,537. His 2.80% of the shares are now owned by corporate insiders.
Mettler-Toledo International Institutional Trading
Institutional investors have recently changed positions in the company. Vanguard Group Inc. increased his stake in Mettler-Toledo International by 0.4% in the third quarter. Vanguard Group Inc. owns 2,543,808 shares in a medical device supplier worth $2,757,793,000 after he purchased an additional 9,778 shares last quarter. BlackRock Inc. raised his stake in Mettler-Toledo International by 2.1% in the third quarter. BlackRock Inc. now owns 2,124,634 shares of the medical device supplier worth $2,303,358,000 after he purchased an additional 42,805 shares during the previous quarter. FMR LLC increased its stake in Mettler-Toledo International by 18.0% in the second quarter. FMR LLC now owns 790,953 shares of the medical device supplier worth $98622,000 after purchasing an additional 120,718 shares during the previous quarter. Fiera Capital Corp increased its stake in Mettler-Toledo International by 0.4% in the second quarter. Fiera Capital Corp now owns 563,657 shares of the medical device supplier, valued at $647,513,000, after purchasing an additional 2,432 shares during the previous quarter. Finally, Alliancebernstein LP increased its stake in Mettler-Toledo International by 39.4% in the third quarter. Alliancebernstein LP now owns 462,256 shares in the medical device supplier valued at $51141,000 after purchasing an additional 130,768 shares during the previous quarter. 91.94% of the shares are owned by institutional investors and hedge funds.
About Mettler Toledo International
(get rating)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. US Business, Swiss Business, Western Europe Business, China Business and Other He operates in five segments. The company’s lab equipment includes laboratory balances, liquid pipetting solutions, automated lab reactors, titrators, pH meters, process analytical sensor and analyzer technology, physical value analyzers, thermal analysis systems, and other analytical instruments. . LabX is a laboratory software platform for managing and analyzing data generated from its instruments.
read more
This instant news alert was generated by Narrative Science Technology and MarketBeat financial data to provide our readers with the fastest and most accurate reporting. This article was reviewed by MarketBeat’s editorial team prior to publication. Send any questions or comments about this story to contact@marketbeat.com.
Hear this before considering Mettler Toledo International.
MarketBeat tracks Wall Street’s most acclaimed and top performing research analysts and the stocks they recommend to clients every day. MarketBeat has identified five stocks top analysts are quietly whispering to clients to buy now before the broader market catches on…and Mettler Toledo International is not on the list was.
Mettler Toledo International currently has a ‘Hold’ rating among analysts, but top-rated analysts believe these five stocks are the better buys.
See 5 stocks here
